DD270305A5 - Verfahren zur herstellung von neuen benzofuron-2-yl-imidozol-derivaten - Google Patents
Verfahren zur herstellung von neuen benzofuron-2-yl-imidozol-derivaten Download PDFInfo
- Publication number
- DD270305A5 DD270305A5 DD87305902A DD30590287A DD270305A5 DD 270305 A5 DD270305 A5 DD 270305A5 DD 87305902 A DD87305902 A DD 87305902A DD 30590287 A DD30590287 A DD 30590287A DD 270305 A5 DD270305 A5 DD 270305A5
- Authority
- DD
- German Democratic Republic
- Prior art keywords
- imidazole
- group
- prepared
- methyl
- benzofuran
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 31
- 150000001875 compounds Chemical class 0.000 claims abstract description 24
- 125000004432 carbon atom Chemical group C* 0.000 claims abstract description 15
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 12
- 229910052736 halogen Inorganic materials 0.000 claims abstract description 11
- 150000002367 halogens Chemical class 0.000 claims abstract description 11
- 125000004093 cyano group Chemical group *C#N 0.000 claims abstract description 9
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims abstract description 9
- 125000003277 amino group Chemical group 0.000 claims abstract description 6
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims abstract description 6
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims abstract description 3
- 125000003884 phenylalkyl group Chemical group 0.000 claims abstract description 3
- 125000003545 alkoxy group Chemical group 0.000 claims abstract 3
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 claims description 32
- -1 acetamino group Chemical group 0.000 claims description 17
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 17
- 125000004244 benzofuran-2-yl group Chemical group [H]C1=C(*)OC2=C([H])C([H])=C([H])C([H])=C12 0.000 claims description 14
- 150000003839 salts Chemical class 0.000 claims description 8
- 238000002360 preparation method Methods 0.000 claims description 6
- 239000007858 starting material Substances 0.000 claims description 6
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 5
- 239000003795 chemical substances by application Substances 0.000 claims description 5
- FBAOVPVVMDOHPK-UHFFFAOYSA-N 2-(1h-imidazol-2-ylsulfinyl)-1h-imidazole Chemical compound N=1C=CNC=1S(=O)C1=NC=CN1 FBAOVPVVMDOHPK-UHFFFAOYSA-N 0.000 claims description 4
- 239000000460 chlorine Substances 0.000 claims description 4
- 239000003960 organic solvent Substances 0.000 claims description 3
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 2
- 238000009835 boiling Methods 0.000 claims description 2
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 2
- 229910052794 bromium Inorganic materials 0.000 claims description 2
- 229910052801 chlorine Inorganic materials 0.000 claims description 2
- 230000002140 halogenating effect Effects 0.000 claims description 2
- NHZMMYPUEMYBRW-UHFFFAOYSA-N 1-[(5-bromo-1-benzofuran-2-yl)-phenylmethyl]imidazole Chemical compound C=1C2=CC(Br)=CC=C2OC=1C(N1C=NC=C1)C1=CC=CC=C1 NHZMMYPUEMYBRW-UHFFFAOYSA-N 0.000 claims 1
- IIMDUSGYHAIYAK-UHFFFAOYSA-N 1-[(5-chloro-1-benzofuran-2-yl)-(2,5-dichlorophenyl)methyl]imidazole Chemical compound ClC1=CC=C(Cl)C(C(C=2OC3=CC=C(Cl)C=C3C=2)N2C=NC=C2)=C1 IIMDUSGYHAIYAK-UHFFFAOYSA-N 0.000 claims 1
- XNLQAWKCIRZDDY-UHFFFAOYSA-N 1-[(5-chloro-1-benzofuran-2-yl)-phenylmethyl]imidazole Chemical compound C=1C2=CC(Cl)=CC=C2OC=1C(N1C=NC=C1)C1=CC=CC=C1 XNLQAWKCIRZDDY-UHFFFAOYSA-N 0.000 claims 1
- GXHPBBGIDNRSFQ-UHFFFAOYSA-N 1-[1-benzofuran-2-yl-[4-(2-phenylethenyl)phenyl]methyl]imidazole Chemical compound C=1C=CC=CC=1C=CC(C=C1)=CC=C1C(C=1OC2=CC=CC=C2C=1)N1C=CN=C1 GXHPBBGIDNRSFQ-UHFFFAOYSA-N 0.000 claims 1
- MIIRMTCUUGENPA-UHFFFAOYSA-N 5,7-dichloro-1-benzofuran-2-carbaldehyde Chemical compound ClC1=CC(Cl)=C2OC(C=O)=CC2=C1 MIIRMTCUUGENPA-UHFFFAOYSA-N 0.000 claims 1
- 125000000068 chlorophenyl group Chemical group 0.000 claims 1
- 150000007522 mineralic acids Chemical class 0.000 claims 1
- 231100000252 nontoxic Toxicity 0.000 claims 1
- 230000003000 nontoxic effect Effects 0.000 claims 1
- 150000007524 organic acids Chemical class 0.000 claims 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 18
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 18
- 238000002844 melting Methods 0.000 description 16
- 230000008018 melting Effects 0.000 description 16
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 12
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 12
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 9
- IANQTJSKSUMEQM-UHFFFAOYSA-N 1-benzofuran Chemical compound C1=CC=C2OC=CC2=C1 IANQTJSKSUMEQM-UHFFFAOYSA-N 0.000 description 8
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 7
- 239000000203 mixture Substances 0.000 description 6
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 5
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 5
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 5
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 4
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 4
- 230000000844 anti-bacterial effect Effects 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- PFKFTWBEEFSNDU-UHFFFAOYSA-N carbonyldiimidazole Chemical compound C1=CN=CN1C(=O)N1C=CN=C1 PFKFTWBEEFSNDU-UHFFFAOYSA-N 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 239000002541 mycostatic Substances 0.000 description 3
- 230000001557 mycostatic effect Effects 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 239000008194 pharmaceutical composition Substances 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- VBFQIUOSXHUWCT-UHFFFAOYSA-N 2-(1-benzofuran-2-yl)-1h-imidazole Chemical class C1=CNC(C=2OC3=CC=CC=C3C=2)=N1 VBFQIUOSXHUWCT-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical group C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- 206010064899 Vulvovaginal mycotic infection Diseases 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 125000002252 acyl group Chemical group 0.000 description 2
- 230000000843 anti-fungal effect Effects 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- 229960004217 benzyl alcohol Drugs 0.000 description 2
- 235000019445 benzyl alcohol Nutrition 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- NEHMKBQYUWJMIP-UHFFFAOYSA-N chloromethane Chemical compound ClC NEHMKBQYUWJMIP-UHFFFAOYSA-N 0.000 description 2
- 239000012043 crude product Substances 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 229940079865 intestinal antiinfectives imidazole derivative Drugs 0.000 description 2
- 150000002576 ketones Chemical class 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 230000002685 pulmonary effect Effects 0.000 description 2
- SMQUZDBALVYZAC-UHFFFAOYSA-N salicylaldehyde Chemical compound OC1=CC=CC=C1C=O SMQUZDBALVYZAC-UHFFFAOYSA-N 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- XPNGNIFUDRPBFJ-UHFFFAOYSA-N (2-methylphenyl)methanol Chemical compound CC1=CC=CC=C1CO XPNGNIFUDRPBFJ-UHFFFAOYSA-N 0.000 description 1
- VKTQADPEPIVMHK-UHFFFAOYSA-N (2-phenylphenyl)methanol Chemical compound OCC1=CC=CC=C1C1=CC=CC=C1 VKTQADPEPIVMHK-UHFFFAOYSA-N 0.000 description 1
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- IRVOHCBKGFGSAE-UHFFFAOYSA-N (3-methyl-1-benzofuran-2-yl)-phenylmethanol Chemical compound O1C2=CC=CC=C2C(C)=C1C(O)C1=CC=CC=C1 IRVOHCBKGFGSAE-UHFFFAOYSA-N 0.000 description 1
- FGQZVPZMZJBGIY-UHFFFAOYSA-N (5-bromo-1-benzofuran-2-yl)-phenylmethanol Chemical compound C=1C2=CC(Br)=CC=C2OC=1C(O)C1=CC=CC=C1 FGQZVPZMZJBGIY-UHFFFAOYSA-N 0.000 description 1
- BJUOOKZVEFFPTC-UHFFFAOYSA-N 1-[(3-methyl-1-benzofuran-2-yl)-phenylmethyl]imidazole Chemical compound O1C2=CC=CC=C2C(C)=C1C(N1C=NC=C1)C1=CC=CC=C1 BJUOOKZVEFFPTC-UHFFFAOYSA-N 0.000 description 1
- KMZJOBCVGQULHS-UHFFFAOYSA-N 1-[(5-chloro-1-benzofuran-2-yl)-(2-chlorophenyl)methyl]imidazole;hydrochloride Chemical compound Cl.C=1C2=CC(Cl)=CC=C2OC=1C(N1C=NC=C1)C1=CC=CC=C1Cl KMZJOBCVGQULHS-UHFFFAOYSA-N 0.000 description 1
- DHWFNOFHAXHQDS-UHFFFAOYSA-N 1-[(5-chloro-1-benzofuran-2-yl)-phenylmethyl]imidazole;hydrochloride Chemical compound Cl.C=1C2=CC(Cl)=CC=C2OC=1C(N1C=NC=C1)C1=CC=CC=C1 DHWFNOFHAXHQDS-UHFFFAOYSA-N 0.000 description 1
- NSOSOBDKQBWMFY-UHFFFAOYSA-N 1-[1-benzofuran-2-yl(phenyl)methyl]imidazole;hydrochloride Chemical compound Cl.C1=NC=CN1C(C=1C=CC=CC=1)C1=CC2=CC=CC=C2O1 NSOSOBDKQBWMFY-UHFFFAOYSA-N 0.000 description 1
- WJYBJTFOVOOBPY-UHFFFAOYSA-N 1-[1-benzofuran-2-yl-(2-methoxyphenyl)methyl]imidazole;hydrochloride Chemical compound Cl.COC1=CC=CC=C1C(N1C=NC=C1)C1=CC2=CC=CC=C2O1 WJYBJTFOVOOBPY-UHFFFAOYSA-N 0.000 description 1
- MVKWZIBMSDANRY-UHFFFAOYSA-N 1-[1-benzofuran-2-yl-(4-fluorophenyl)methyl]imidazole;hydrochloride Chemical compound Cl.C1=CC(F)=CC=C1C(N1C=NC=C1)C1=CC2=CC=CC=C2O1 MVKWZIBMSDANRY-UHFFFAOYSA-N 0.000 description 1
- VTABMSWWBJYCPH-UHFFFAOYSA-N 1-[1-benzofuran-2-yl-(4-nitrophenyl)methyl]imidazole;hydrochloride Chemical compound Cl.C1=CC([N+](=O)[O-])=CC=C1C(N1C=NC=C1)C1=CC2=CC=CC=C2O1 VTABMSWWBJYCPH-UHFFFAOYSA-N 0.000 description 1
- BHDJNYNPQFRNSX-UHFFFAOYSA-N 1-benzofuran-2-yl(phenyl)methanol Chemical compound C=1C2=CC=CC=C2OC=1C(O)C1=CC=CC=C1 BHDJNYNPQFRNSX-UHFFFAOYSA-N 0.000 description 1
- AMJVVFHJMVZGEM-UHFFFAOYSA-N 1-benzofuran-2-yl-(2-chlorophenyl)methanol Chemical compound C=1C2=CC=CC=C2OC=1C(O)C1=CC=CC=C1Cl AMJVVFHJMVZGEM-UHFFFAOYSA-N 0.000 description 1
- NIDNSGORHMQLTR-UHFFFAOYSA-N 1-benzofuran-2-yl-(4-fluorophenyl)methanol Chemical compound C=1C2=CC=CC=C2OC=1C(O)C1=CC=C(F)C=C1 NIDNSGORHMQLTR-UHFFFAOYSA-N 0.000 description 1
- HGUFODBRKLSHSI-UHFFFAOYSA-N 2,3,7,8-tetrachloro-dibenzo-p-dioxin Chemical compound O1C2=CC(Cl)=C(Cl)C=C2OC2=C1C=C(Cl)C(Cl)=C2 HGUFODBRKLSHSI-UHFFFAOYSA-N 0.000 description 1
- DKLCLFQKBDSYNI-UHFFFAOYSA-N 2-[bromo-(2-methylphenyl)methyl]-1-benzofuran Chemical compound CC1=CC=CC=C1C(Br)C1=CC2=CC=CC=C2O1 DKLCLFQKBDSYNI-UHFFFAOYSA-N 0.000 description 1
- 125000004182 2-chlorophenyl group Chemical group [H]C1=C([H])C(Cl)=C(*)C([H])=C1[H] 0.000 description 1
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 1
- KMTDMTZBNYGUNX-UHFFFAOYSA-N 4-methylbenzyl alcohol Chemical compound CC1=CC=C(CO)C=C1 KMTDMTZBNYGUNX-UHFFFAOYSA-N 0.000 description 1
- JKTYGPATCNUWKN-UHFFFAOYSA-N 4-nitrobenzyl alcohol Chemical compound OCC1=CC=C([N+]([O-])=O)C=C1 JKTYGPATCNUWKN-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 241001480043 Arthrodermataceae Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 201000007336 Cryptococcosis Diseases 0.000 description 1
- 241000221204 Cryptococcus neoformans Species 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- IIUZTXTZRGLYTI-UHFFFAOYSA-N Dihydrogriseofulvin Natural products COC1CC(=O)CC(C)C11C(=O)C(C(OC)=CC(OC)=C2Cl)=C2O1 IIUZTXTZRGLYTI-UHFFFAOYSA-N 0.000 description 1
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 1
- 241000453701 Galactomyces candidum Species 0.000 description 1
- 235000017388 Geotrichum candidum Nutrition 0.000 description 1
- UXWOXTQWVMFRSE-UHFFFAOYSA-N Griseoviridin Natural products O=C1OC(C)CC=C(C(NCC=CC=CC(O)CC(O)C2)=O)SCC1NC(=O)C1=COC2=N1 UXWOXTQWVMFRSE-UHFFFAOYSA-N 0.000 description 1
- 241000893980 Microsporum canis Species 0.000 description 1
- 241000893976 Nannizzia gypsea Species 0.000 description 1
- DDUHZTYCFQRHIY-UHFFFAOYSA-N Negwer: 6874 Natural products COC1=CC(=O)CC(C)C11C(=O)C(C(OC)=CC(OC)=C2Cl)=C2O1 DDUHZTYCFQRHIY-UHFFFAOYSA-N 0.000 description 1
- 241000228143 Penicillium Species 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- 241001465752 Purpureocillium lilacinum Species 0.000 description 1
- 241000223252 Rhodotorula Species 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- ARFYUEZWYRMBSO-UHFFFAOYSA-N [4-(2-phenylethenyl)phenyl]methanol Chemical compound C1=CC(CO)=CC=C1C=CC1=CC=CC=C1 ARFYUEZWYRMBSO-UHFFFAOYSA-N 0.000 description 1
- 241000222126 [Candida] glabrata Species 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 229910000288 alkali metal carbonate Inorganic materials 0.000 description 1
- 150000008041 alkali metal carbonates Chemical class 0.000 description 1
- 150000003973 alkyl amines Chemical group 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000001532 anti-fungicidal effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- BTFJIXJJCSYFAL-UHFFFAOYSA-N arachidyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 description 1
- 230000001588 bifunctional effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 150000008280 chlorinated hydrocarbons Chemical class 0.000 description 1
- NEHMKBQYUWJMIP-NJFSPNSNSA-N chloro(114C)methane Chemical compound [14CH3]Cl NEHMKBQYUWJMIP-NJFSPNSNSA-N 0.000 description 1
- KBFBRIPYVVGWRS-UHFFFAOYSA-N cloridarol Chemical compound C=1C2=CC=CC=C2OC=1C(O)C1=CC=C(Cl)C=C1 KBFBRIPYVVGWRS-UHFFFAOYSA-N 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 230000037304 dermatophytes Effects 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 235000019256 formaldehyde Nutrition 0.000 description 1
- 229960004279 formaldehyde Drugs 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000012458 free base Substances 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 238000004362 fungal culture Methods 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000003349 gelling agent Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- DDUHZTYCFQRHIY-RBHXEPJQSA-N griseofulvin Chemical compound COC1=CC(=O)C[C@@H](C)[C@@]11C(=O)C(C(OC)=CC(OC)=C2Cl)=C2O1 DDUHZTYCFQRHIY-RBHXEPJQSA-N 0.000 description 1
- 229960002867 griseofulvin Drugs 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 125000001475 halogen functional group Chemical group 0.000 description 1
- 239000001307 helium Substances 0.000 description 1
- 229910052734 helium Inorganic materials 0.000 description 1
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 150000002460 imidazoles Chemical class 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000003589 local anesthetic agent Substances 0.000 description 1
- 229960005015 local anesthetics Drugs 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 229940050176 methyl chloride Drugs 0.000 description 1
- 239000012452 mother liquor Substances 0.000 description 1
- 150000002825 nitriles Chemical class 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- LIGACIXOYTUXAW-UHFFFAOYSA-N phenacyl bromide Chemical class BrCC(=O)C1=CC=CC=C1 LIGACIXOYTUXAW-UHFFFAOYSA-N 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 239000002798 polar solvent Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- ZYTJPPRBIGGXRO-UHFFFAOYSA-N propan-2-ylalumane Chemical compound C(C)(C)[AlH2] ZYTJPPRBIGGXRO-UHFFFAOYSA-N 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Chemical group COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 229910000033 sodium borohydride Inorganic materials 0.000 description 1
- 239000012279 sodium borohydride Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 229940084106 spermaceti Drugs 0.000 description 1
- 239000012177 spermaceti Substances 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 238000011200 topical administration Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000009278 visceral effect Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT8609461A IT1216256B (it) | 1986-08-13 | 1986-08-13 | (benzofuran-2-il) imidazoli, con attivita' farmacologica,loro sali e procedimenti di fabbricazione relativi. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DD270305A5 true DD270305A5 (de) | 1989-07-26 |
Family
ID=11130481
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DD87305902A DD270305A5 (de) | 1986-08-13 | 1987-08-11 | Verfahren zur herstellung von neuen benzofuron-2-yl-imidozol-derivaten |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US4800208A (cs) |
| EP (1) | EP0257171B1 (cs) |
| JP (1) | JPS6372687A (cs) |
| AR (1) | AR243181A1 (cs) |
| AT (1) | ATE56008T1 (cs) |
| AU (1) | AU604042B2 (cs) |
| CA (1) | CA1325212C (cs) |
| CS (1) | CS272226B2 (cs) |
| DD (1) | DD270305A5 (cs) |
| DE (1) | DE3673822D1 (cs) |
| DK (1) | DK166917B1 (cs) |
| ES (1) | ES2037011T3 (cs) |
| GR (1) | GR3000903T3 (cs) |
| HU (1) | HU202864B (cs) |
| IE (1) | IE61019B1 (cs) |
| IT (1) | IT1216256B (cs) |
| MX (1) | MX7723A (cs) |
| NO (1) | NO170085C (cs) |
| PL (1) | PL149009B1 (cs) |
| PT (1) | PT85491B (cs) |
| SU (1) | SU1600630A3 (cs) |
| YU (1) | YU46222B (cs) |
| ZA (1) | ZA875908B (cs) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0574992A1 (en) * | 1992-06-17 | 1993-12-22 | Glaxo Group Limited | 5-(1,2,4-Triazol-1-ylmethyl)-3H-isobenzofuran-1-one derivatives, their preparation and use as aromatase inhibitors |
| GB9212833D0 (en) * | 1992-06-17 | 1992-07-29 | Glaxo Group Ltd | Chemical compounds |
| US5426196A (en) * | 1993-12-22 | 1995-06-20 | Glaxo Inc. | Synthesis of diaryl methanes |
| IT1286866B1 (it) * | 1996-10-28 | 1998-07-17 | Menarini Farma Ind | Composti furano-eterociclici,loro preparazione ed uso come inibitori di aromatasi |
| US6503935B1 (en) | 1998-08-07 | 2003-01-07 | Abbott Laboratories | Imidazoles and related compounds as α1A agonists |
| RU2139872C1 (ru) * | 1998-12-22 | 1999-10-20 | Кубанский государственный технологический университет | 2,4-диметил-3-(5-нитрофурфурил)-пиразол, обладающий способностью активировать прорастание семян пшеницы |
| GB0223915D0 (en) * | 2002-10-15 | 2002-11-20 | Univ Cardiff | Benzofuran derivatives formulations and uses thereof |
| US8367113B2 (en) | 2006-05-15 | 2013-02-05 | Massachusetts Institute Of Technology | Polymers for functional particles |
| CN105770878A (zh) | 2007-10-12 | 2016-07-20 | 麻省理工学院 | 疫苗纳米技术 |
| US7762049B2 (en) | 2008-12-31 | 2010-07-27 | Black & Decker Inc. | Electric mower having two-motion activation system |
| CN112063532B (zh) * | 2020-08-11 | 2022-05-24 | 浙江工业大学 | 林生地霉及其制备(s)-1-(2-三氟甲基苯基)乙醇的应用 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR6915465D0 (pt) * | 1969-03-07 | 1973-01-04 | Bayer Ag | Processo para preparar n-benzimidazois substituidos na posicao alfa por heterociclos penta-membrados com atividade antimicotica |
| DE2009020C3 (de) * | 1970-02-26 | 1979-09-13 | Bayer Ag, 5090 Leverkusen | Verfahren zur Herstellung von N-(l,l,l-trisubstituierten)-Methylazolen |
| US3928348A (en) * | 1970-03-23 | 1975-12-23 | Bayer Ag | N-methyl-imidazole derivatives and their production |
| IT1154888B (it) * | 1980-11-12 | 1987-01-21 | Menarini Sas | Derivati del benzofurano 2-sostituiti e relativi metodi di preparazione |
| DE3049542A1 (de) * | 1980-12-31 | 1982-07-29 | Basf Ag, 6700 Ludwigshafen | Azolylalkyl-2,3-dihydrobenzofurane, diese enthaltende fungizide und verfahren zu ihrer herstellung |
| ZA825413B (en) * | 1981-08-26 | 1983-06-29 | Pfizer | Thromboxane synthetase inhibitors, processes for their production, and pharmaceutical compositions comprising them |
| FI842502A7 (fi) * | 1983-06-27 | 1984-12-28 | Ciba Geigy Ag | Foerfarande foer framstaellning av nya 2-substituerade bensofuran derivat. |
| DE3413363A1 (de) * | 1984-04-09 | 1985-10-17 | Merz + Co GmbH & Co, 6000 Frankfurt | Benzofuran-2-yl-ethyl-imidazolderivate, verfahren zu ihrer herstellung und pharmazeutische mittel |
-
1986
- 1986-08-13 IT IT8609461A patent/IT1216256B/it active
- 1986-12-11 AT AT86830370T patent/ATE56008T1/de not_active IP Right Cessation
- 1986-12-11 DE DE8686830370T patent/DE3673822D1/de not_active Expired - Lifetime
- 1986-12-11 ES ES198686830370T patent/ES2037011T3/es not_active Expired - Lifetime
- 1986-12-11 EP EP86830370A patent/EP0257171B1/en not_active Expired - Lifetime
-
1987
- 1987-07-30 AR AR87308306A patent/AR243181A1/es active
- 1987-08-05 PT PT85491A patent/PT85491B/pt not_active IP Right Cessation
- 1987-08-11 ZA ZA875908A patent/ZA875908B/xx unknown
- 1987-08-11 DD DD87305902A patent/DD270305A5/de not_active IP Right Cessation
- 1987-08-11 DK DK418187A patent/DK166917B1/da not_active IP Right Cessation
- 1987-08-12 IE IE215387A patent/IE61019B1/en not_active IP Right Cessation
- 1987-08-12 NO NO873383A patent/NO170085C/no unknown
- 1987-08-12 PL PL1987267298A patent/PL149009B1/pl unknown
- 1987-08-12 CA CA000544286A patent/CA1325212C/en not_active Expired - Fee Related
- 1987-08-12 MX MX772387A patent/MX7723A/es unknown
- 1987-08-12 AU AU76799/87A patent/AU604042B2/en not_active Ceased
- 1987-08-12 HU HU873653A patent/HU202864B/hu not_active IP Right Cessation
- 1987-08-12 SU SU874203231A patent/SU1600630A3/ru active
- 1987-08-13 JP JP62201044A patent/JPS6372687A/ja active Pending
- 1987-08-13 US US07/085,067 patent/US4800208A/en not_active Expired - Fee Related
- 1987-08-13 YU YU150787A patent/YU46222B/sh unknown
- 1987-08-13 CS CS875978A patent/CS272226B2/cs unknown
-
1990
- 1990-10-04 GR GR90400548T patent/GR3000903T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HUT46910A (en) | 1988-12-28 |
| YU46222B (sh) | 1993-05-28 |
| NO170085C (no) | 1992-09-09 |
| NO170085B (no) | 1992-06-01 |
| NO873383D0 (no) | 1987-08-12 |
| NO873383L (no) | 1988-02-15 |
| PT85491B (pt) | 1990-06-29 |
| EP0257171A1 (en) | 1988-03-02 |
| IT1216256B (it) | 1990-02-22 |
| AU7679987A (en) | 1988-02-18 |
| ES2037011T3 (es) | 1993-06-16 |
| ATE56008T1 (de) | 1990-09-15 |
| IE872153L (en) | 1988-02-13 |
| CA1325212C (en) | 1993-12-14 |
| DE3673822D1 (de) | 1990-10-04 |
| IE61019B1 (en) | 1994-09-07 |
| EP0257171B1 (en) | 1990-08-29 |
| PL267298A1 (en) | 1988-12-08 |
| YU150787A (en) | 1988-10-31 |
| CS272226B2 (en) | 1991-01-15 |
| ZA875908B (en) | 1988-02-12 |
| SU1600630A3 (ru) | 1990-10-15 |
| DK418187A (da) | 1988-02-14 |
| PT85491A (en) | 1987-09-01 |
| MX7723A (es) | 1993-12-01 |
| CS597887A2 (en) | 1990-03-14 |
| AR243181A1 (es) | 1993-07-30 |
| IT8609461A0 (it) | 1986-08-13 |
| HU202864B (en) | 1991-04-29 |
| DK418187D0 (da) | 1987-08-11 |
| DK166917B1 (da) | 1993-08-02 |
| JPS6372687A (ja) | 1988-04-02 |
| AU604042B2 (en) | 1990-12-06 |
| US4800208A (en) | 1989-01-24 |
| PL149009B1 (en) | 1989-12-30 |
| GR3000903T3 (en) | 1991-12-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE1620262C3 (de) | Spiro [4.5] decanderivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zubereitungen | |
| DE1940388C3 (de) | l-(ß-Aryl) äthylimidazolderivate, ihre Herstellung und diese enthaltende fungizide und bakterizide Mittel | |
| DE2037610C3 (cs) | ||
| DE2105490A1 (de) | Imidazolderivate, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel | |
| DE2423987A1 (de) | Metallkomplexe von azolylaethern, verfahren zu ihrer herstellung sowie ihre verwendung als fungizide | |
| DE2041771B2 (de) | derivate | |
| DE2623129A1 (de) | Neue tertiaere imidazolylalkohole, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel | |
| DE2321330A1 (de) | Azolyl-amidine, verfahren zu ihrer herstellung sowie ihre verwendung als herbizide | |
| DD270305A5 (de) | Verfahren zur herstellung von neuen benzofuron-2-yl-imidozol-derivaten | |
| DE2712023A1 (de) | Sulfonamidoaminobenzoesaeurederivate, solche enthaltende arzneimittel sowie verfahren zur herstellung derselben | |
| DE2921660A1 (de) | 5-nitroimidazolderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende antiprotozoen-mittel | |
| DE2044172C3 (de) | Pyrrolderivate, ein Verfahren zu ihrer Herstellung und Arzneimittel | |
| DE3010093A1 (de) | 1,1-diphenyl-2-(1.2.4-triazol-1-yl)-aethan-1-ole, verfahren zu ihrer herstellung und diese enthaltende therapeutische mittel | |
| DE1914571B2 (de) | L-3hydroxy-6-oxomorphinan-verbindungen | |
| EP0018360B1 (de) | N-(5-Methoxybentofuran-2-ylcarbonyl)-N'-benzylpiperazin und Verfahren zu dessen Herstellung | |
| DE2242454A1 (de) | 1-aethyl-imidazole, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel | |
| DE69424215T2 (de) | Verfahren zur Herstellung von 1-(1,2,4-Triazol-1-yl)-propan-2-ol-Derivaten | |
| DE69500329T2 (de) | Neue Triazol-Verbindung mit fungizider Wirkung, deren Herstellung und Verwendung | |
| DE3305495A1 (de) | Piperazin- und homopiperazinderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zubereitungen | |
| DE2053080A1 (de) | N substituierte Imidazole, Ver fahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel | |
| DE2457309A1 (de) | 2-phenylhydrazinothiazolin- beziehungsweise 2-phenylhydrazinothiazininderivate sowie ihre verwendung und verfahren zur herstellung derselben | |
| DE2022206C3 (de) | Basisch substituierte Diphenylazolyl-essigsäureester, Verfahren zu ihrer Herstellung sowie diese Verbindungen enthaltende Arzneimittel | |
| DE2917244A1 (de) | 4'-substituierte 2,4-dichlor- alpha (imidazol-n-ylmethyl)-dibenzylaether, verfahren zu deren herstellung sowie solche enthaltende arzneimittel | |
| DE3876546T2 (de) | Ethanon-oxime. | |
| DE3033380C2 (cs) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ENJ | Ceased due to non-payment of renewal fee |